Suchergebnisse - "Cavanna, Luigi"

PubPharm (41)

1

Brief Report : Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171)

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Piccirillo, M. | Chu, Q. | Bradbury, P. | +32

CommentIn: J Thorac Oncol. 2023 Jun;18(6):e67-e68. - PMID 37210188

2

Implementation of Precision Oncology in Clinical Practice : Results of a National Survey for Health Care Professionals

enthalten in: The oncologist | 2023

von Fasola, G. | Barducci, M. | Pelizzari, G. | +9

3

INOVATYON/ ENGOT-ov5 study : Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

enthalten in: British journal of cancer | 2023

von Colombo, N. | Gadducci, A. | Sehouli, J. | +139

4

Guideline Application in Real world : multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey

enthalten in: ESMO open | 2023

von Reni, M. | Giommoni, E. | Bergamo, F. | +119

5

Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)

enthalten in: Scientific reports | 2023

von Celio, L. | Cortinovis, D. | Cogoni, A. | +18

6

Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer : results of the multicenter, single arm, phase IV PAINTER study

enthalten in: Breast cancer research : BCR | 2022

von La Verde, N. | Damia, G. | Garrone, O. | +24

7

Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2021

von Bazarbachi, A. | Labopin, M. | Kröger, N. | +17

8

Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2021

von Llombart-Cussac, A. | Pérez-García, J. | Bellet, M. | +52

ErratumIn: JAMA Oncol. 2021 Nov 1;7(11):1729. - PMID 34792545

9

Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin : A Randomized Noninferiority Study

enthalten in: The oncologist | 2021

von Celio, L. | Cortinovis, D. | Cogoni, A. | +18

10

Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer : Survival analyses of the CHER-Lob trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Guarneri, V. | Dieci, M. | Griguolo, G. | +16

1
2
3
4
5
Nächster »
[5]